Ypeginterferon alfa-2b
- Generic Name
- Ypeginterferon alfa-2b
A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: Granulocyte-macrophage colony stimulating factor
- First Posted Date
- 2015-01-06
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT02332473
- Locations
- 🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China
🇨🇳Henan Provincial People's Hospital, Zhengzhou, Henan, China
🇨🇳Tongji Hospital, Huazhong University of Science & Technology, Wuhan, Hubei, China
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
- First Posted Date
- 2013-01-03
- Last Posted Date
- 2015-08-31
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 820
- Registration Number
- NCT01760122
- Locations
- 🇨🇳
Beijing Youan Hospital, Capital Medical University, Beijing, China
🇨🇳Xiangya Hospital, Central-south University, Changsha, China
🇨🇳Xiangya Second Hospital, Central-south University, Changsha, China
Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients
- First Posted Date
- 2012-04-20
- Last Posted Date
- 2014-10-07
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 770
- Registration Number
- NCT01581398
- Locations
- 🇨🇳
85 Militay Hospital, Shanghai, China
🇨🇳Huashan Hospital, Shanghai, China
🇨🇳Xiangya Hospital, Central-south University, Changsha, China
Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2010-06-14
- Last Posted Date
- 2013-02-04
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 205
- Registration Number
- NCT01143662
- Locations
- 🇨🇳
Tianjin Third Central Hospital, Tianjin, China
🇨🇳First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
🇨🇳Tangdu Hospital, Fourth Military Medical University, Xian, China
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
- Conditions
- Chronic Hepatitis C
- Interventions
- First Posted Date
- 2010-06-10
- Last Posted Date
- 2013-02-04
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 211
- Registration Number
- NCT01140997
- Locations
- 🇨🇳
302 Military Hospital, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, China
🇨🇳Xiangya Second Hospital, Central-south University, Changsha, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.